retatrutide what is retatrutide clinical trial Dosing Schedule: Proven 2026 Guide Retatrutide (“reta”) is an experimental

Research suggests that GIP may actually reduce some of the gastrointestinal side effects associated with pure GLP-1 agonists, which explains why Retatrutide causes less nausea (28%) than semaglutide (44%) despite being more potent for weight loss

doi: 10.1186/s12933-021-01401-8 23 MaiorinoMISignorielloSMaioAChiodiniPBellastellaGScappaticcioL

2017;53(2):S13142

The lyophilized powder should be protected from moisture, light, and extreme temperatures , and repeated freezethaw cycles should be avoided

Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Glp-1 Receptor Agonists: A Multidisciplinary Expert Consensus